Individually tailored treatment with epirubicin and paclitaxel with or without capecitabine as first-line chemotherapy in metastatic breast cancer: a randomized multicenter trial

T. Hatschek, L. Carlsson, Z. Einbeigi, E. Lidbrink, B. Linderholm, B. Lindh, Niklas Loman, M. Malmberg, S. Rotstein, M. Soderberg, M. Sundquist, T. M. Walz, M. Hellstrom, H. Svensson, G. Astrom, Y. Brandberg, J. Carstensen, Mårten Fernö, J. Bergh

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Individually tailored treatment with epirubicin and paclitaxel with or without capecitabine as first-line chemotherapy in metastatic breast cancer: a randomized multicenter trial'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science